Michael J. Evans
10Patents
2h-index
22Co-inventors
54Inventor score
Filing activity: Aug 28, 2001 → Feb 25, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7179912B2 | Materials and methods to potentiate cancer treatment | Chemistry; Metallurgy | 55 | Expired |
| US9365542B2 | Modulators of resistant androgen receptor | Chemistry; Metallurgy | 3 | Active |
| US9650359B2 | Modulators of resistant androgen receptor | Chemistry; Metallurgy | 2 | Active |
| US10450294B2 | Modulators of resistant androgen receptor | Chemistry; Metallurgy | 1 | Active |
| US11072594B2 | Trioxolane agents | Emerging Cross-Sectional Technologies | 1 | Active |
| US12139470B2 | Trioxolane agents | Emerging Cross-Sectional Technologies | 0 | Active |
| US10919929B2 | Glucocorticoid inhibitors for treatment of prostate cancer | Physics | 0 | Active |
| US8242115B2 | Materials and methods to potentiate cancer treatment | Chemistry; Metallurgy | 0 | Active |
| US11739069B2 | Modulators of resistant androgen receptor | Chemistry; Metallurgy | 0 | Active |
| US11446400B2 | Free PSA antibodies as diagnostics, prognostics and therapeutics for prostate cancer | Physics | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.